biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Here's the bottom line.

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Dec 13, 2022 11:09pm

185 Views

Post# 35170064

RE:RE:RE:RE:RE:RE:RE:RE:Here's the bottom line.

Uncle, this may be difficult. Pay attention. Consider this statement:

"If this happens, then that can happen."

That's two sides of the coin. Implicit is that if this does not happen, then the other thing won't happen.

And that is how I have always spoken about Bioasis, but all that you ever filtered out of it was "this is going to happen," something that I would never allow myself to say.

Too bad, but that's how it is.

I use a clip manager for writing. Hundreds of clips stored in EditPro. I actually have a clip, ready to paste into my writing, "If xB3 works as hoped".

I have used it on this forum probably hundreds of times.

You probably don't recall me ever using it.

jd

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading